Methylglyoxal – an advanced glycation end products (AGEs) precursor – Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE)
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Jaap Schouten Foundation
This publication has 67 references indexed in Scilit:
- Mesenchymal Stem Cells in Bone RegenerationAdvances in Wound Care, 2013
- Autophagy: Renovation of Cells and TissuesCell, 2011
- Non-enzymatic glycation alters microdamage formation in human cancellous boneBone, 2010
- Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE LigandsDiabetes, 2009
- Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cellsArthritis Research & Therapy, 2009
- Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protectionMolecular and Cellular Biochemistry, 2009
- Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stressFree Radical Biology and Medicine, 2009
- Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral OssificationMolecular and Cellular Biology, 2007
- Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stressMolecular Nutrition & Food Research, 2005
- Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994